Susquehanna Fundamental Investments, LLC Novo Cure LTD Transaction History
Susquehanna Fundamental Investments, LLC
- $6.94 Billion
- Q1 2025
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 170,346 shares of NVCR stock, worth $3.16 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
170,346Holding current value
$3.16 Million% of portfolio
0.04%Shares
8 transactions
Others Institutions Holding NVCR
# of Institutions
279Shares Held
73.4MCall Options Held
1.4MPut Options Held
389K-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$209 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$166 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$96.9 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$50.9 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.95B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...